Noom Med lists compounded tirzepatide at $249/mo semaglutide.
Best suited to: Coaching-first patients who value the app ecosystem.
Current reporting indicates Noom does not sell compounded tirzepatide, and that figures attributed to it describe brand-name Zepbound billed separately from its programme fee. We publish no compounded tirzepatide price for it rather than carry a number that may describe a different product. Its semaglutide programme is unaffected.
Both sources agree on the structure — a $149 introductory period rolling to roughly $299/mo — but Noom bills in 12-week cycles rather than calendar months, so the effective monthly figure depends on where you are in the cycle.
Price at every dose tier
This is the table that matters. The advertised figure applies to the starter dose you will occupy for roughly four weeks; the row you should budget from is 10 mg.
| Dose tier | Per month | Twelve months at this dose |
|---|---|---|
| 2.5 mg · Starter (weeks 1–4) | — | — |
| 5 mg · First treatment dose | — | — |
| 7.5 mg · Escalation | — | — |
| 10 mg · Common maintenance | — | — |
| 12.5 mg · Escalation | — | — |
| 15 mg · Maximum dose | — | — |
Noom Med official pricing page → The provider’s own page, not a commercial link. Check the price there against ours — if they differ, ours is wrong and we want to know.
Pricing source: GLP-1 Tirzepatide Rank data export; corroborated by Policy Lab, 28 Jul 2026. Last verified 2026-08-05.
| Criterion | Published? | Points |
|---|---|---|
| Price published at all six dose tiers | Not published | 0/25 |
| Price does not rise as the dose escalates | Yes | 20/20 |
| Dispensing pharmacy or prescriber identified by name | Yes | 15/15 |
| No separate recurring membership fee | Yes | 10/10 |
| Prepaid term and its rate published | Yes | 10/10 |
| State availability published | Yes | 10/10 |
| Delivery formats published | Yes | 10/10 |
Tailor Made Compounding named as the dispensing pharmacy.
What works
- Behavioral coaching and habit tools bundled with medication
- 66,000+ Trustpilot review base
What to check before enrolling
- $149 starter rolls to $299/mo after the intro window
- 12-week billing cycles confuse cancellation timing
- Not available in AL, LA, MS
Clinical and pharmacy disclosure
| Medication type | Compounded |
|---|---|
| Pharmacy disclosure | Tailor Made Compounding (503A) |
| Formulations | injection |
| Pricing model | Flat at every dose tier |
| Membership fee | None disclosed |
| Shipping | Included |
| State availability | 47 states claimed — confirm yours |
| Semaglutide offered | $249 per month |
| Prices last verified | 2026-08-05 |
Refund mechanics after a shipment leaves the pharmacy, the specific compounding pharmacy where it is not named above, and whether the quoted rate holds at renewal. Ask for all three in writing before you pay. If a program will not answer in writing, that is itself an answer — see our nine-point verification checklist.
If Noom Med is not the right fit
The cheapest tracked flat-rate program is IVIM Health at $133 per month. For FDA-approved product rather than compounded, LillyDirect self-pay Zepbound vials run $299–$449 depending on strength — see the Zepbound cost breakdown.
Why Noom Med has no price on this page
We publish prices we can interpret. A figure advertised without the dose it applies to, the billing period it covers or what it includes is not a price, it is a number, and reproducing it in a comparison table would make our table worse rather than more complete.
This is not an accusation of bad faith. Programs price behind an intake for ordinary commercial reasons. But a comparison site exists to make costs visible before you commit, and a program that reveals its cost only after you have supplied contact details and a health history has opted out of that comparison.
What to ask Noom Med before supplying any information
- What is the total monthly cost at a 10 mg maintenance dose, including every fee?
- Does that figure change as the dose escalates?
- Is there a membership, consultation or shipping charge on top?
- Which compounding pharmacy fills the prescription?
- What is refundable, and what notice is required to cancel?
If those five are answered in writing, the program has effectively published its pricing and we will record it. Send us the answers through contact and they will appear here with the date they were verified.
Priced alternatives
Every other program in our index publishes a figure we could record at all six dose tiers. The cheapest over twelve months is Oak Longevity at about $2,388.
More on Noom Med
How much does Noom Med cost?
Noom Med does not publish tirzepatide pricing in a form we can interpret, so we publish no figure rather than estimating one. For a comparable published price, Oak Longevity runs about $2,388 for a first year.
Is Noom Med worth considering?
Possibly, but not on the basis of a price you cannot see. Ask for the monthly cost at 10 mg including every fee, in writing, before supplying a medical history.
What Noom Med includes, and what it bills separately
Noom Med charges no separate recurring platform fee, so the advertised figure and the figure on your statement are the same thing. That is worth more than it sounds: membership stacking is the mechanism by which a headline number becomes a substantially larger invoice, and it is invisible in most comparison tables because they compare medication prices rather than totals.
Noom Med commitment terms in practice
No discounted prepaid term is published, which means Noom Med is not asking you to put money at risk before you know whether you tolerate the drug — and is not offering a lower rate for accepting that risk either. For a first three months that is the safer structure; for a stable long-term patient it leaves a discount on the table that some competitors offer.
Who should not choose Noom Med
Anyone who expects to hold a low maintenance dose permanently, because flat pricing is worst value at the bottom of the ladder — you would be paying a maintenance rate for a starter dose. Anyone who needs an FDA-approved product, since this is a compounded preparation that FDA does not review for safety, effectiveness or quality before marketing. And anyone who cannot get a straight answer to the pharmacy question, whatever the price.
How Noom Med fits the wider market
Entry pricing across the 21 tracked compounded programs runs $133 to $399 a month for the identical molecule from the same category of licensed pharmacy, and the cheapest route holds a 10 mg maintenance dose at $199. Noom Med does not publish a comparable figure. Nothing about the medicine differs across that spread; what differs is overhead, clinical wrap, pharmacy sourcing and margin. Use the projector to price your own maintenance dose across all of them rather than accepting any single program's framing, including this page's.
What would change our record of Noom Med
Four things. A published price we can verify at a dose tier currently blank. A named dispensing pharmacy with a checkable state licence. A change to the pricing model, in either direction. Or a correction from a reader or from the program itself with a source we can check. All four are logged with the date they changed, and the underlying record is in the open dataset rather than locked inside a page.
We do not accept payment to change any of it, and no program has editorial input into what appears here. Where a program disputes a figure, the fastest route is to publish the correct one publicly — at which point we record it, date it and move on.
Noom Med and the compounded-versus-brand decision
This is a compounded route. FDA does not approve compounded drugs and does not review them for safety, effectiveness or quality before marketing, which is the honest reason it costs a fraction of the brand price. What you retain is a licensed pharmacy under a state board, a prescriber who can decline, and at good operations batch sterility and potency testing you can ask about.
Neither choice is obviously right. What is wrong is making it without knowing which one you are buying, and the marketing in this market frequently blurs exactly that line — which is why every page here states the regulatory status plainly rather than in a footer.
Using Noom Med well if you do enrol
Fix a weekly injection day and keep it. Record the dose, the date and the injection site each week. Photograph any shipment that arrives warm before opening it further. Diary the renewal date if there is an introductory rate. And re-price the market annually at your actual maintenance dose — no program tells its existing patients when a competitor drops below it, and the cheapest tracked route currently holds maintenance at $199 a month, about $2,388 for a year.
Noom Med tirzepatide: what patients get wrong most often
Four mistakes recur, and all four are expensive. Judging the drug on the first month, when the starter dose is not a treatment dose and a flat scale predicts nothing. Comparing programs on the advertised price, which describes four weeks of a twelve-month course. Treating a plateau as failure rather than as the expected shape of the trial curves. And stopping for cost without pricing the market first, when the spread between the cheapest and dearest route to the identical molecule runs from $133 to $399 a month at entry.
The fifth, less common but more serious, is buying outside the licensed channel because a price looked unbeatable. Research-labelled peptide sold without a prescription is a different market with no clinical oversight and no accountability if something goes wrong, and the disclaimer that it is not for human consumption exists so the seller can say you were told.
Noom Med tirzepatide: the three-year view
Current evidence treats obesity pharmacotherapy as ongoing while it remains effective, tolerated and appropriate, and the withdrawal data show substantial regain after stopping. That makes three years a more honest planning horizon than twelve months. At the cheapest tracked route, holding a 10 mg maintenance dose for three years costs roughly $7,164; at the dearest compounded route it is several times that for the same molecule. Deciding on a first-month price is deciding on the least representative number available.
Noom Med tirzepatide: what would change this page
New trial evidence, a change in the labelling, a shift in the compounding framework, or a correction from a reader. Clinical statements here follow the prescribing information and the published trial program; price figures carry a verification date and sit in a downloadable dataset. Where the evidence is genuinely limited — long-term data beyond the trial horizon, bioavailability of compounded oral preparations, the human relevance of the rodent thyroid finding — this site says so rather than filling the gap with confident language, and updates rather than defends when better evidence arrives.
People also ask about Noom Med tirzepatide
Is Noom Med legit?
Noom Med dispenses through a licensed pharmacy with a prescriber review, and scores 75/100 on our disclosure criteria — a measure of what it publishes before you pay, not of clinical quality. Verify the pharmacy name and prescriber licensure yourself before enrolling; our checklist covers how.
How much is Noom Med tirzepatide at 10 mg?
Noom Med does not publish a tirzepatide price in a form we can interpret, so we publish no figure for it rather than estimating one.
Does Noom Med charge a membership fee?
No separate recurring membership fee is charged on top of the medication price.
Can I cancel Noom Med?
Cancellation terms vary and compounded medication is generally not refundable once it has shipped. Ask what notice is required before the next billing cycle, and get the answer in writing before you pay for any multi-month term.
How much does Noom Med tirzepatide cost per month in 2026?
Compounded tirzepatide runs from $133 per month at the entry dose across the 21 compounded programs we track. At a 10 mg maintenance dose the cheapest tracked route is Oak Longevity at $199 per month, or about $2,388 for a first year on the standard escalation. Brand Zepbound through manufacturer self-pay sits well above that and pharmacy retail well above again. Verified 2026-08-05.
Is Noom Med tirzepatide FDA-approved?
Brand tirzepatide (Zepbound and Mounjaro) is FDA-approved. Compounded tirzepatide is not: FDA does not approve compounded drugs and does not review them for safety, effectiveness or quality before they are marketed. The active molecule is the same; the regulatory review is not.
Primary sources
Clinical, dosing and regulatory statements on this page rest on the documents below. Links go to the publisher, not to a summary of it. Prices are not sourced here — they carry a verification date instead, and the reason is set out in the source ledger.
- ZEPBOUND (tirzepatide) full prescribing information — DailyMed, US National Library of Medicine. Dose ladder, contraindications, warnings, storage.
- FDA’s concerns with unapproved GLP-1 drugs used for weight loss — US Food and Drug Administration. Compounded GLP-1 risks, API import alert, cold-chain complaints.
- FD&C Act provisions that apply to human drug compounding — US Food and Drug Administration. Why a compounded preparation is lawful without being FDA-approved.
- Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1) — N Engl J Med 2022;387:205-216. Registration NCT04184622. The weight-reduction and adverse-event figures used across this site.
- The full source ledger — every primary source, what it supports, the date we read it, and the claims we deliberately do not source.